Matsumoto M - Search Results

1

Forty-two-day-old boy with acute idiopathic thrombocytopenic purpura.

Kato K, Kobayashi C, Katayama Y, Moriyama N, Shiono J, Kudo K, Koike K, Aoki K, Fujisawa K, Okada M, Matsumoto M, Fujimura Y, Tsuchida M. Kato K, et al. Among authors: matsumoto m. Pediatr Int. 2010 Jun;52(3):485-7. doi: 10.1111/j.1442-200X.2010.03037.x. Pediatr Int. 2010. PMID: 20723123 No abstract available.

2

Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.

Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. Fujimura Y, et al. Among authors: matsumoto m. Int J Hematol. 2002 Jan;75(1):25-34. doi: 10.1007/BF02981975. Int J Hematol. 2002. PMID: 11843286 Review.

3

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.

Mori Y, Wada H, Gabazza EC, Minami N, Nobori T, Shiku H, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y. Mori Y, et al. Among authors: matsumoto m. Transfusion. 2002 May;42(5):572-80. doi: 10.1046/j.1537-2995.2002.00100.x. Transfusion. 2002. PMID: 12084165

4

Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): important discrimination from Upshaw-Schulman syndrome.

Ashida A, Nakamura H, Yoden A, Tamai H, Ishizashi H, Yagi H, Matsumoto M, Fujimura Y. Ashida A, et al. Among authors: matsumoto m. Am J Hematol. 2002 Dec;71(4):318-22. doi: 10.1002/ajh.10228. Am J Hematol. 2002. PMID: 12447964 Free article.

5

Intensive plasma IgG removal therapy for severe thrombotic thrombocytopenic purpura.

Amano SY, Inoue M, Yoshida Y, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y, Yoshioka A. Amano SY, et al. Among authors: matsumoto m. Int J Hematol. 2002 Dec;76(5):474-6. doi: 10.1007/BF02982815. Int J Hematol. 2002. PMID: 12512844 No abstract available.

6

[vWF-cleaving protease/ADAMTS 13].

Matsumoto M, Yagi H, Fujimura Y. Matsumoto M, et al. Rinsho Ketsueki. 2003 Mar;44(3):159-67. Rinsho Ketsueki. 2003. PMID: 12722342 Review. Japanese. No abstract available.

7

VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.

Kokame K, Matsumoto M, Fujimura Y, Miyata T. Kokame K, et al. Among authors: matsumoto m. Blood. 2004 Jan 15;103(2):607-12. doi: 10.1182/blood-2003-08-2861. Epub 2003 Sep 25. Blood. 2004. PMID: 14512308 Free article.

8

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

Matsumoto M, Yagi H, Ishizashi H, Wada H, Fujimura Y. Matsumoto M, et al. Semin Hematol. 2004 Jan;41(1):68-74. doi: 10.1053/j.seminhematol.2003.10.009. Semin Hematol. 2004. PMID: 14727261

9

Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura.

Uchida T, Wada H, Mizutani M, Iwashita M, Ishihara H, Shibano T, Suzuki M, Matsubara Y, Soejima K, Matsumoto M, Fujimura Y, Ikeda Y, Murata M; Research Project on Genetics of Thrombosis. Uchida T, et al. Among authors: matsumoto m. Blood. 2004 Oct 1;104(7):2081-3. doi: 10.1182/blood-2004-02-0715. Epub 2004 May 4. Blood. 2004. PMID: 15126318 Free article.

10

[Changes of ADAMTS13 activity and endothelial cell markers in TMA cases].

Mori Y, Wada H, Shiku H, Yagi H, Matsumoto M, Fujimura Y. Mori Y, et al. Among authors: matsumoto m. Rinsho Ketsueki. 2004 May;45(5):378-82. Rinsho Ketsueki. 2004. PMID: 15199746 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,856 results

Search Page

Filters